The use of selective serotonin reuptake inhibitors in eating disorders

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 15, 1998, Pages 28-34

  Mayer, Laurel E S ^a,b   Walsh, B Timothy ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; PAROXETINE; PHENTERMINE; PHENTOLAMINE MESYLATE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIBUTRAMINE; UNCLASSIFIED DRUG;

ANOREXIA NERVOSA; BINGE EATING DISORDER; BULIMIA; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EATING DISORDER; HUMAN; OBESITY; OBSESSION; PRIORITY JOURNAL; REVIEW;

ANOREXIA NERVOSA; ANTIDEPRESSIVE AGENTS; BULIMIA; CLINICAL TRIALS; COMBINED MODALITY THERAPY; EATING DISORDERS; FLUOXETINE; HUMANS; OBESITY; PSYCHOTHERAPY; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0031671453     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. American Psychiatric Association. Practice Guideline for Eating Disorders. Am J Psychiatry 1993;150:212-228
2. Garner DM, Garfinkel PE, eds. Handbook of Treatment for Eating Disorders. New York, NY: Guilford Press; 1997
3. Ferguson JM. Treatment of an anorexia nervosa patient with fluoxetine [letter]. Am J Psychiatry 1987;144:1239
4. Gwirtsman HE, Guze BH, Yager J, et al. Fluoxetine treatment of anorexia nervosa: an open clinical trial. J Clin Psychiatry 1990;51:378-382
5. Attia E, Haiman C, Walsh BT, et al. Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am J Psychiatry 1998;155:548-551
6. Kaye WH, Weltzin TE, Hsu G, et al. Relapse prevention with fluoxetine in anorexia nervosa: a double-blind placebo-controlled study. In: New Research Program and Abstracts of the 150th Annual Meeting of the American Psychiatric Association; May 21, 1997; San Diego, Calif. Abstract NR405:178
7. Strober M, Freeman R, DeAntonio M, et al. Does adjunctive fluoxetine influence the post-hospital course of anorexia nervosa? a 24-month prospective, longitudinal follow-up and comparison with historical controls. Psychopharmacol Bull 1997;33:425-431
8. Agras WS, Dorian B, Kirkley BG, et al. Imipramine in the treatment of bulimia: a double-blind controlled study. Int J Eat Disord 1987;6:29-38
9. Home RL, Ferguson JM, Pope HG Jr, et al. Treatment of bulimia with bupropion: a multicenter controlled trial. J Clin Psychiatry 1988;49:262-266
10. Hughes PL, Wells LA, Cunningham CJ, et al. Treating bulimia with desipramine: a double-blind, placebo-controlled study. Arch Gen Psychiatry 1986;43:182-186
11. Mitchell JE, Groat R. A placebo-controlled, double-blind trial of amitriptyline in bulimia. J Clin Psychopharmacol 1984;4:186-193
12. Pope HG Jr, Hudson JI, Jonas JM, et al. Bulimia treated with imipramine: a placebo-controlled, double-blind study. Am J Psychiatry 1983;140: 554-558
13. Pope HG Jr, Keck PE Jr, McElroy SL, et al. A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol 1989;9:254-259
14. Sabine EJ, Yonace A, Farrington AJ, et al. Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin. Br J Clin Pharmacol 1983;15(suppl 2):195S-202S
15. Walsh BT, Gladis M, Roose SP, et al. Phenelzine vs placebo in 50 patients with bulimia. Arch Gen Psychiatry 1988;45:471-475
16. Walsh BT, Hadigan CM, Devlin MJ, et al. Long-term outcome of antidepressant treatment for bulimia nervosa. Am J Psychiatry 1991;148: 1206-1212
17. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry 1992;49:139-147
18. Goldstein DJ, Wilson MG, Thompson VL, et al. Fluoxetine Bulimia Nervosa Collaborative Study Group. Long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatry 1995;166:660-666
19. Roberts JM, Lydiard RB. Sertraline in the treatment of bulimia nervosa [letter]. Am J Psychiatry 1993;150:1753
20. Spigset O, Pleym H. Case report of successful treatment of bulimia nervosa with fluvoxamine [letter]. Pharmacopsychiatry 1991;24:180
21. Ayuso-Gutierrez JL, Palazon M, Ayuso-Mateos JL. Open trial of fluvoxamine in the treatment of bulimia nervosa. Int J Eat Disord 1994;15: 245-249
22. Pigott TA, Sunderland BA, Horn L, et al. A pilot study of paroxetine in the treatment of patients with bulimia nervosa. In: New Research Program and Abstracts of the 149th Annual Meeting of the American Psychiatric Association; May 7, 1996; New York, NY. Abstract NR416:181
23. Wilson GT, Fairburn CG, Agras WS. Cognitive-behavioral therapy for bulimia nervosa. In: Garner DM, Garfinkel PE, eds. Handbook of Treatment for Eating Disorders. New York, NY: Guilford Press; 1997:67-93
24. Fichter MM, Leibl K, Rief W, et al. Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 1991;24:1-7
25. Fichter MM, Kruger R, Rief W, et al. Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology. J Clin Psychopharmacol 1996;16:9-18
26. Goldbloom DS, Olmsted M, Davis R, et al. A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome. Behav Res Ther 1997;35:803-811
27. Beumont PJ, Russell JD, Touyz SW, et al. Intensive nutritional counselling in bulimia nervosa: a role for supplementation with fluoxetine? Aust N Z J Psychiatry 1997;31:514-524
28. Walsh BT, Wilson GT, Loeb KL, et al. Medication and psychotherapy in the treatment of bulimia nervosa. Am J Psychiatry 1997;154:523-531
29. Spitzer RL, Devlin MJ, Walsh BT, et al. Binge eating disorder: a multisite field trial for the diagnostic criteria. Int J Eat Disord 1992;11:191-203
30. Spitzer RL, Yanovski S, Wadden T, et al. Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 1993;13:137-153
31. Wilson GT, Nonas CA, Rosenblum GD. Assessment of binge eating in obese patients. Int J Eat Disord 1993;13:25-33
32. de Zwaan M, Nutzinger DO, Schoenbeck G. Binge eating in overweight women. Compr Psychiatry 1992;33:256-261
33. Prats M, Diez-Quevedo C, Avila C, et al. Paroxetine treatment for bulimia nervosa and binge eating disorder. Presented at the International Conference on Eating Disorders; 1994; New York, NY
34. Devlin MJ. Treatment of binge eating disorder with psychotherapy and medication. Proceedings of the 7th International Conference on Eating Disorders: April 26-28, 1996; New York, NY
35. Hudson JI, McElroy SL, Raymond NC, et al. Fluvoxamine treatment of binge-eating disorder: a multicenter, placebo-controlled trial. In: New Research Program and Abstracts of the 147th Annual Meeting of the American Psychiatric Association; May 26, 1994; Philadelphia, Pa. Abstract NR620:218
36. Marcus MD, Wing RR, Ewing L, et al. A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge eaters. Am J Psychiatry 1990;147:876-881
37. Ferguson JM, Feighner JP. Fluoxetine-induced weight loss in overweight non-depressed humans. Int J Obes 1987;11(suppl 3):163-170
38. Pijl H, Koppeschaar HP, Willekens FL, et al. Effect of serotonin re-uptake inhibition by fluoxetine on body weight and spontaneous food choice in obesity. Int J Obes 1991;15:237-242
39. Levine LR, Rosenblatt S, Bosomworth J. Use of a serotonin re-uptake inhibitor, fluoxetine, in the treatment of obesity. Int J Obes 1987;11(suppl 3):185-190
40. Levine LR, Enas GG, Thompson WL, et al. Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub). Int J Obes 1989;13: 635-645
41. Goldstein DJ, Rampey AH Jr, Enas GG, et al. Fluoxetine: a randomized clinical trial in the treatment of obesity. Int J Obes Relat Metab Disord 1994;18:129-135
42. Darga LL, Carroll-Michals L, Botsford SJ, et al. Fluoxetine's effect on weight loss in obese subjects. Am J Clin Nutr 1991;54:321-325
43. Szkudlarek J, Elsborg L. Treatment of severe obesity with a highly selective serotonin re-uptake inhibitor as a supplement to a low-calorie diet. Int J Obes Relat Metab Disord 1993;17:681-683
44. Wadden TA, Bartlett SJ, Foster GD, et al. Sertraline and relapse prevention training following treatment by very-low-calorie diet: a controlled clinical trial. Obes Res 1995;3:549-557